EVOK
Price
$2.54
Change
+$0.12 (+4.96%)
Updated
Apr 24, 04:56 PM (EDT)
Capitalization
5.17M
PRFX
Price
$2.30
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
3.06M
26 days until earnings call
Ad is loading...

EVOK vs PRFX

Header iconEVOK vs PRFX Comparison
Open Charts EVOK vs PRFXBanner chart's image
Evoke Pharma
Price$2.54
Change+$0.12 (+4.96%)
Volume$100
Capitalization5.17M
PainReform
Price$2.30
Change-$0.00 (-0.00%)
Volume$525
Capitalization3.06M
EVOK vs PRFX Comparison Chart
Loading...
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVOK vs. PRFX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVOK is a Buy and PRFX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (EVOK: $2.42 vs. PRFX: $2.30)
Brand notoriety: EVOK and PRFX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EVOK: 54% vs. PRFX: 3%
Market capitalization -- EVOK: $5.17M vs. PRFX: $3.06M
EVOK [@Pharmaceuticals: Other] is valued at $5.17M. PRFX’s [@Pharmaceuticals: Other] market capitalization is $3.06M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVOK’s FA Score shows that 0 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • EVOK’s FA Score: 0 green, 5 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, both EVOK and PRFX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVOK’s TA Score shows that 5 TA indicator(s) are bullish while PRFX’s TA Score has 6 bullish TA indicator(s).

  • EVOK’s TA Score: 5 bullish, 3 bearish.
  • PRFX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, PRFX is a better buy in the short-term than EVOK.

Price Growth

EVOK (@Pharmaceuticals: Other) experienced а +12.56% price change this week, while PRFX (@Pharmaceuticals: Other) price change was +15.58% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.61%. For the same industry, the average monthly price growth was -4.57%, and the average quarterly price growth was -11.30%.

Reported Earning Dates

EVOK is expected to report earnings on Mar 13, 2025.

PRFX is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EVOK($5.17M) has a higher market cap than PRFX($3.06M). PRFX YTD gains are higher at: -31.446 vs. EVOK (-45.249). EVOK has higher annual earnings (EBITDA): -7.29M vs. PRFX (-9.57M). PRFX has more cash in the bank: 8.03M vs. EVOK (4.74M). PRFX has less debt than EVOK: PRFX (86K) vs EVOK (5M). EVOK has higher revenues than PRFX: EVOK (5.18M) vs PRFX (0).
EVOKPRFXEVOK / PRFX
Capitalization5.17M3.06M169%
EBITDA-7.29M-9.57M76%
Gain YTD-45.249-31.446144%
P/E RatioN/A2.92-
Revenue5.18M0-
Total Cash4.74M8.03M59%
Total Debt5M86K5,814%
FUNDAMENTALS RATINGS
EVOK: Fundamental Ratings
EVOK
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVOKPRFX
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POWI47.160.92
+1.99%
Power Integrations
PHX3.940.06
+1.55%
PHX Minerals
XERS4.130.03
+0.73%
Xeris Biopharma Holdings
ALZN0.69N/A
N/A
Alzamend Neuro Inc.
INSM70.74-0.50
-0.70%
Insmed

EVOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVOK has been loosely correlated with RDHL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EVOK jumps, then RDHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVOK
1D Price
Change %
EVOK100%
-3.20%
RDHL - EVOK
33%
Loosely correlated
-2.60%
NBIX - EVOK
28%
Poorly correlated
+1.45%
EOLS - EVOK
26%
Poorly correlated
+7.36%
PRFX - EVOK
25%
Poorly correlated
+2.68%
EVO - EVOK
24%
Poorly correlated
+2.90%
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and EVOK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and EVOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
+2.68%
EVOK - PRFX
24%
Poorly correlated
-3.20%
AMRX - PRFX
24%
Poorly correlated
+0.69%
LFCR - PRFX
21%
Poorly correlated
+2.43%
AYURF - PRFX
21%
Poorly correlated
N/A
KMDA - PRFX
21%
Poorly correlated
+1.70%
More